Viewing Study NCT02724020


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-03-01 @ 6:00 AM
Study NCT ID: NCT02724020
Status: COMPLETED
Last Update Posted: 2021-11-19
First Post: 2016-03-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear-cell Metastatic Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View